drugset
drugset / Trial / NCT01747941

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

NCT01747941 ↗

Phase 1 Completed 30 enrolled Pfizer
RandomizedCrossoverDouble-blindBasic science

Summary

The study is designed to test safety tolerability and PK of single oral ascending doses of PF-06305591,

Timeline

Start
2012-11
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06305591 Small molecule — Oral

Indications

No indication recorded.